1 Followers
25 Following
trendinghealthcarenews

trendinghealthcarenews

Advanced Wound Care Market share Analysis Global Trends Statistics, Size Share, Company Profiles 2027

Wound care market research report, Product (Wound Therapy Devices, Traditional and Active Wound  Care  Products),  Type  (Chronic,  Acute),  Application  (Ulcers,  Burn,  Trauma  Wounds),  End  Users  (Hospitals,  Clinics, Trauma  Center)  -  Global forecast  till  2027

get free sample copy @ https://www.marketresearchfuture.com/sample_request/926

Market Insight

As per the latest study by Market Research Future (MRFR), by 2027, the Advanced Wound Care Market will showcase a stellar performance by recording the value of USD 29,900 Mn. The said figure will be almost the double of the market value of USD 15,456.2 Mn it achieved in 2016, in addition to growing at a lucrative CAGR during the forecast period (2016-2027).

As per the World Health Organization (WHO), in the year 2014, 9% of the world’s deaths were caused by injuries. Several chronic wound conditions like arterial ulcers, venous ulcers as well as diabetic ulcers compromise the body’s restorative capabilities. In addition to diminishing the quality of life, unhealed wounds also increase the risk of infections as well as complications. Hence, wound care has been established as an integral part of surgical recovery or disease management and is an expanding medical specialty.

Market Segmentation

The market for wound care is segmented on the basis of product, type, application, and end-user.

The wound care market, by product, has been segmented into advanced wound management products, wound therapy devices, traditional wound care products, wound care products, and active wound care products. Among these, the advanced wound management products segment will be noting a high surge in terms of global demand as it ensures faster healing, mitigating the possibility of infection. Furthermore, the active wound care products segment and wound care products segment are predicted to grab a comparatively smaller share of the market over the projected timeframe.

The types of wound care in the market include chronic wound and acute wound. The chronic wound segment is set to acquire the largest share of the total market, accounting for 60.3% market share, in 2016. The segment will be most likely retaining the substantial share it has amassed, over the next few years.

Competitive Dashboard

The leading companies mentioned in the MRFR report are Kinetic Concepts Inc, 3M, Baxter, B. Braun Melsungen AG Inc, Ethicon, ConvaTec, Smith & Nephew, and so on.

Industry Update

January 2019 – Redsense Medical has announced the development of a prototype that has fully functional optical measuring which is based on the smart wound technology. The smart wound care technology will help develop thin sensor layers for the optical measuring of various physiological as well as biological parameters like blood as well as exudate.

Get full report @ https://www.marketresearchfuture.com/reports/wound-care-market-926

The wound care market continuously experiences various technological advancements that are emerging as a standard solution for treating acute and chronic wounds. With time, conventional measures of wound care management are being replaced with advanced wound measure products owing to the effectiveness of the latter enabling faster healing. Furthermore, the treatment in advanced wound care includes intervention therapies along with the use of products like antimicrobial dressings, foam dressings, collagen products, gauze, hydrogels, hydrocolloids, alginate dressings, and film dressings.

Related Latest Trending Reports

Bone Densitometers Market Research Report- Forecast to 2022

 

Anti Epilepsy Drugs Market

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Microscopy Market 2020 share Upcoming Trends, Emerging Growth, Key Players Segments and Forecast

Microscope, Scanning Probe Microscope (Spm), Others), By Application (Life Science, Material Science, Pathology), By End User (Hospitals & Clinics, Academic & Research Institutes, Diagnostics Centers) - Forecast Till 2022

 

Market Research Future (MRFR) in recently published study asserts that the global Microscopy market is expected to reach USD ~10.5 Billion in 2022; it has been noted that market is growing at steady pace and is expected to grow at the CAGR of 7.8% during the forecasted period 2016 – 2022. Surpassing its previous growth records in terms of value & volume, the market is expected to gain prominence over the forecasted period.

 

Factors substantiating the market growth include the increased funding by the public and private sector for life science research studies and the expansion of the semiconductor industries in most of the emerging nations. Increasing research and development activities initiated by governments, schools, universities and research institutions across the developing regions have fuelled the growth of the market.

 

get free sample copy @ https://www.marketresearchfuture.com/sample_request/2313

 

Global Microscopy Device Market – Regional Analysis

 

Globally, Asia-Pacific is the largest market for microscopy devices. The APAC market is expected to grow further registering 7.3% CAGR during 2016-2022. North America market for microscopy devices accounting for the second-largest market globally will grow at 11.5% CAGR during the assessment period.

 

Microscopy Device Market – Competitive Analysis

 

The Microscopy Device market is widely expanded and highly competitive with the presence of numerous major and small players operating at the international and regional level around the globe. The market will witness fierce competition due to the expected extensions in product & service and product innovations. Manufacturers operating in the Microscopy Device market strive to develop Device with adept technology with unrivalled design and features.

 

Get full report @ https://www.marketresearchfuture.com/reports/microscopy-devices-market-2313

 

Key Players:

 

FEI, Meiji Techno, Nikon Metrology NV, Woodley Equipment Company Ltd, Radical Scientific Equipments Pvt. Ltd, Bruker, Mauna Kea Technologies SA, Icon Analytical Equipment Pvt. Ltd, Olympus Corporation, NIDEK Inc., Sonix, Inc., Konan Medical USA Inc., Carl Zeiss, and Leica Microsystems are some of the prominent players at the forefront of competition in the Global Microscopy Device Market and are profiled in MRFR Analysis.

 

Industry/ Innovation/ Related News

 

November 2017 – Researchers of Germany and Portugal collaboratively developed the first microscope to concurrently monitor movement and neuron activity in zebrafish larvae without interfering with their behavior. To enable wider use in the research community, the neurobehavioral tracking microscope uses off-the-shelf components and is open source.

Browse other healthcare-related reports

 

Anti Epilepsy Drugs Market

Peptic Ulcer Drugs Market

 

About Market Research Future:

 

MRFR team has supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country-level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Bone Densitometers Market size Analysis 2020, Industry Report Analysis, Technology Advancement

Bone Densitometers Market Research Report- Global Forecast to 2022 segmented by type (central scanners, peripheral scanners and others), by technology (quantitative computed tomography (QCT), radiographic absorptiometry (RA), single x-ray absorptiometry (SXA), dual-energy x-ray absorptiometry (DXA) and others), by end user (hospitals, orthopedic clinics, academic & research institutes and others), Confirms MRFR

get free sample copy @ https://www.marketresearchfuture.com/sample_request/2300

Leading Market Players

General Electric Company, Hologic, Inc., Swissray, Osteosys Co. Ltd, MedWrench, LLC, Schick Sirona, DMS Imaging, Echolight S.p.a., Aarna Systems And Wellness Pvt. Ltd., Tecnicare Healthcare Company and others.

Bone Densitometers Market Analysis

Bone densitometry is a non-invasive technology that can measure bone mass. Devices useful for this are known as bone densitometers. Market Research Future (MRFR) has published and released a research report about the global Bone Densitometers Market size that anticipates aggrandizement for this market with 5.3% CAGR (Compound Annual Growth Rate) during the forecast period between 2016 and 2022. In terms of cash, the market is expected to rise to US $ 1.2 bn.

Analyzing the market structure, this report evaluates the future growth potential of the market. It observes the strategies of the key players in the market and follows the competitive developments like joint ventures, new product developments, mergers and acquisitions, research and developments (R & D) in the market.

Bone Densitometers Market Segmentation

Based on the type, the market has been segmented into central scanners, peripheral scanners, and others.

Based on technology, the market segmented into quantitative computed tomography (QCT), radiographic absorptiometry (RA), single x-ray absorptiometry (SXA), dual-energy x-ray absorptiometry (DXA) and others. The QCT and the DXA segment have been assessed to grow at a comparatively higher CAGR through the forecast period, owing to their sharp accuracy and precision levels in comparison with other bone densitometry technologies.

Based on the end-user, the market is segmented into hospitals, orthopedic clinics, academic & research institutes, and others. Among these, the hospital end-user is estimated to account for the largest market share over the forecast period, owing to the growing proclivity of government organization towards the advancement of the healthcare sector and towards the adoption of advanced diagnostic devices, and the increasing use of automated diagnosis systems which has enabled diagnosis of chronic, life-threatening diseases at an early stage.

Browse Complete 84Pages Premium Research Report @

https://www.marketresearchfuture.com/reports/bone-densitometers-market-2300

Analyzing the market structure, this report evaluates the future growth potential of the market. It observes the strategies of the key players in the market and follows the competitive developments like joint ventures, new product developments, mergers and acquisitions, research and developments (R & D) in the market.

Related News

 

mHealth Applications Market 

Wound Care Market

About Market Research Future:

MRFR team has supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country-level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with the technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Hepatitis C Treatment Market 2020 size Global Industry Analysis, Upcoming Trends

Overview

Hepatitis C is the inflammation of liver caused by infection by hepatitis C virus characterized by a host of symptoms such as yellowed eyes and skin due to bilirubin, flu-like symptoms which include nausea, vomiting, poor appetite, joint pain, headaches, clay coloured stools etc. According to the World Health Organisation, hepatitis C affects between 130–150 million people globally every year claiming a toll of 700000 lives. Of those who recover about 15-20% develop liver cirrhosis or liver cancer.

get free sample copy @ https://www.marketresearchfuture.com/sample_request/1569

Market Players

Hoffmann-La Roche Ltd (Switzerland), BMS (U.S), Merck & Co., Inc (U.S), Vertex Pharmaceuticals Incorporated (U.S), Gilead sciences Inc (U.S.)., Abbvie Inc (U.S.), Johnson & Johnson (U.S.), Glaxosmithkline plc (U.K), Novartis AG (Switzerland), Bristol-Myers Squibb (U.S.) are some of the prominent players at the forefront of competition in the Hepatitis C Treatment Market and are profiled in MRFR Analysis.

According to Centres for Disease Control & Prevention, in U.S., liver cancer incidence is increasing at a rapid rate (2.3 % per year overall from 2003 – 2012), second only to thyroid cancer. Moreover, the rate of deaths due to liver cancer is increasing faster than for any other type of cancer. Furthermore, Hepatitis B and C are major contributing factors to liver cancer.

According to American Cancer Society, Worldwide, the most common risk factor for liver cancer is chronic infection with hepatitis B virus (HBV) or hepatitis C virus (HCV). These infections lead to cirrhosis of the liver and are responsible for making liver cancer the most common cancer globally.

The market for hepatitis C diagnosis & treatment is driven by factors such as increasing prevalence of liver cancer, rise in government subsidy and reimbursement especially in U.S., greater screening especially in developing nations, drug abuse and unsafe sex etc. On the other hand, the market constraining factors are self-imitating nature of the disease in a sizable number of patients, challenge of herbal treatment offered at negligible prices especially in developing regions, price war between companies such as between Gilead and Merck, rising urbanization and better sanitation etc.

Global Hepatitis C Diagnosis and Treatment Market-Competitive Analysis

October, 2013 - Janssen (Parent organisation Johnson & Johnson Services, Inc.) acquired investigational NS5A Inhibitor for the treatment of Hepatitis C from GlaxoSmithKline. According to company reports, GSK2336805 is an investigational NS5a replication complex inhibitor in Phase 2 development for the treatment of chronic hepatitis C in adult patients with compensated liver disease, including all stages of liver fibrosis.

October, 2013 - Bristol-Myers Squibb to presented range of new Hepatitis C data at the 2013 American Association for the Study of Liver Diseases (AASLD). According to company reports, Bristol-Myers Squibb’s hepatitis C includes compounds with different mechanisms of action, biologics as well as small molecule direct-acting antivirals. These compounds were being studied as part of multiple treatment regimens with the goal of increasing SVR rates across different patient types. Moreover, company stated NS5A replication complex inhibitor daclatasvir (DCV) had been extensively studied in thousands of patients to date as a foundational agent for multiple DAA-based combination therapies and is currently in Phase III development. DCV has shown antiviral potency and pan-genotypic activity across HCV genotypes in vitro. DCV has a drug-drug interaction profile that supports its continued study in a variety of HCV combination regimens. However, Asunaprevir (ASV) is an NS3 protease inhibitor in Phase III development for hepatitis C as a component of DCV-based treatment regimens. BMS-791325 is a non-nucleoside inhibitor of the NS5B polymerase, currently in Phase II development for hepatitis C as a component of DCV-based treatment regimens. Lambda is an investigational type III interferon that has the potential to offer an alternative to alfa-interferon in patients for whom an interferon-based regimen is required or preferred.

Global Hepatitis C Diagnosis and Treatment Market- Regional Analysis

Depending on geographic region, Hepatitis C diagnosis & treatment market is segmented into four key regions: Americas, Europe, Asia Pacific, and Middle East & Africa. Globally, Americas is the largest market for global Hepatitis C diagnosis and treatment with Europe in the second position. However, the developed regions market is stagnant and will continue to do so with Asia Pacific region particularly India and China rising fast. Asia pacific region is expected to be fastest growing region in hepatitis C diagnosis & treatment market. The African region is expected to be a laggard and will show at most a moderate rate of growth.

Browse Full Report @ https://www.marketresearchfuture.com/reports/hepatitis-c-diagnosis-treatment-market-1569

Browse other healthcare-related reports

 

cancer diagnostics market 

Microscopy Devices Market

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members

Rheumatoid Arthritis Market Size by Type Worldwide 2020 -Global Trends, Share and Industrial Growth Analysis

Global Rheumatoid arthritis market Information, by drug type (Nonsteroidal anti-inflammatory drug type (NSAID), Steroids, Biologic agents) by diagnosis (C-Reactive Protein (CRP) Test, CCP, ESR test) by treatment (Synovectomy, Tendon repair, Joint fusion) - Forecast to 2022

GET FREE SAMPLE COPY @ https://www.marketresearchfuture.com/sample_request/1658

Global Rheumatoid Arthritis Market - Overview

Rheumatoid arthritis is a chronic inflammatory condition that possible can distress more than just the joints. It is found that in some individuals, the disorder also can damage a various parts of body system, including the lungs, skin, eyes, heart and blood vessels. The global rheumatoid arthritis market is expected to grow at a healthy CAGR of ~4% during the forecast period 2017-2022.

Global Rheumatoid Arthritis Market - Competitive Analysis

Pfizer Inc. (U.S), Eli Lilly and company (U.S), Bristol-Myers Squibb Company (U.S), F. Hoffmann-La Roche Ltd (Switzerland), Novartis AG (Switzerland), Vertex Pharmaceuticals Incorporated (U.S), Sanofi (France), AstraZeneca (U.K) are some of the prominent players at the forefront of competition in the Global Rheumatoid Arthritis Market and are profiled in MRFR Analysis. 

Characterized by the presence of several well-established and small players, the global rheumatoid arthritis market size of rheumatoid arthritis appears to be highly competitive and fragmented. With well-established market in the North America region major companies like Pfizer Inc., Eli Lilly and Company, Bristol-Myers Squibb Company, Vertex Pharmaceuticals Incorporated, and various others have their home in the region and generate maximum market share. These companies have expanded their operating unit in various other emerging regions as well. Moreover the other small and medium scale players are generating revenue from local market.

Global Rheumatoid Arthritis Market - Regional Analysis

The global market is segmented into the various regions including Americas, Europe, Asia Pacific, and the Middle East & Africa. The Americas accounts for the largest market share of about more than ~38 market share due to increasing patient pool visiting professionals due to rheumatoid arthritis and favourable governmental conditions for research and development. According to the study conducted by the Centers for Disease Control and Prevention in March 2017 it was estimated that about 54.4 million U.S. adults suffer from arthritis that is approximately about 25% of its population. Arthritis is the key cause of disability, and causing pain, aching, stiffness, and swelling of the joints. The most common type of arthritis is rheumatoid arthritis & osteoarthritis. According to the same study it is expected that by 2040, 78 million i.e. 26% of the U.S. adults of age 18 years or older are anticipated to have doctor-diagnosed arthritis.

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Cell culture Market size Analysis 2020 Global Trends, Size, Opportunities

Media Sera and Reagents- Cell Culture Market Research Report: By Type (Media, Sera and Reagents), By Applications (Cancer Research, Virology, Toxicity Testing, Vaccine Production, Drug Development and Others), By End Users (Research Laboratories, Academic Institutes, Pathology Labs, Others) - Global Forecast Till 2023

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/1170

Global Media Sera and Reagents- Cell Culture Market - Overview

The global media sera and reagents- cell culture market is growing mainly due to the rising incidence of chronic diseases. According to a recent study report published by the Market Research Future, The global media sera and reagents- cell culture market is booming and expected to gain prominence over the forecast period. The market is forecasted to demonstrate a spectacular growth by 2027, surpassing its previous growth records in terms of value with a striking CAGR during the anticipated period (2017 – 2027).

Cell culture is a technique used to study the behaviour of cells independent of whole organism. In this technique, cells are taken from an animal or plant and grown under favourable artificial conditions. There are basically three types of cell culture procedures i.e. primary cell culture, secondary cell culture, and cell line. There are various types of media, and serums are used in cell culture technique such as protein free media, serum free media, chemically defined media, specialty media, classical media, Stem cell media, and lysogeny broth. Whereas, reagents include albumin, amino acids, attachment factors, growth factors and cytokines, hormones, biological buffers, biological detergents, cell dissociation reagents, cell freezing reagents, cell separation reagents and others.

Global Media Sera and Reagents- Cell Culture Market - Competitive Analysis

GE Healthcare, Sigma-Aldrich Corporation, BD Biosciences, VWR International, LLC., EMD Millipore, Lonza Biosciences, and Thermo Fisher Scientific, Inc., Hi-media Laboratories, Biowest, Merck KGaA are some of the prominent players at the forefront of competition in the media sera and reagents- cell culture market and are profiled in MRFR Analysis.

The global media sera and reagents- cell culture market is currently dominated by numerous players.

Thermo Fisher Scientific, Inc. is one of them by holding a strong share in the market. The company provides analytical instruments, reagents and consumables, software, and services for research, analysis, discovery, manufacturing, and diagnostics under Thermo Scientific, Invitrogen, Fisher Scientific, Applied Biosystems, and Unity Lab Services brands worldwide. On Aug. 29, 2017, Thermo Fisher Scientific Inc. announced the acquisition of Patheon N.V., a leading contract development and manufacturing organization.

Browse Full Report @ https://www.marketresearchfuture.com/reports/media-sera-and-reagents-cell-culture-market-1170

 

 Related Reports

 

global microscope devices market

Anti Epilepsy Drugs Market share

About Market Research Future:

MRFR team has supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country-level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Surgical Scalpel Market Application size Analysis 2020 Trends, Size Analysis, Share, Leading players

Surgical Scalpel Market Research Report: By Product (Disposable, Reusable Surgical Scalpel, & Accessories), Material Type (Stainless, High-Grade Carbon Steel), Application (Bariatric, Cardiovascular Surgeries), End User — Global Forecast till 2023

Request Sample Pages:

https://www.marketresearchfuture.com/sample_request/7581

Market Highlights

The global surgical scalpel market is expected to grow at an approximate CAGR of 3.7% during the forecast period, 2018–2023.

The rising number of surgical procedures is one of the key factors driving the surgical scalpel market. According to the Australian Institute of Health and Welfare, during 2015–16, there were 10.6 million hospitalizations, and around 25% hospitalizations involved a surgical procedure.

Segmentation

The global surgical scalpel market applicationis segmented based on product, material type, application, end user, and region.

The global market for surgical scalpel, by product, is segmented into disposable surgical scalpel, reusable surgical scalpel, and accessories. The reusable surgical scalpel segment is further classified as scalpel handles and surgical blades.

Based on material type, the market is segmented into stainless steels, high-grade carbon steels, and others.

Based on end user, the market is segmented into hospitals, clinics, ambulatory surgical centers, nursing centers, reference laboratories, and others.

Key Players

Some of the key players in the global surgical scalpel market are Ansell Sandel Medical Solutions LLC (Ansell), B. Braun Melsungen AG, Beaver-Visitec International, Cincinnati Surgical Company, Inc., Henry Schein, Inc., Hill-Rom Services Inc., Huaiyin Medical Instruments Co., Ltd, Hu-Friedy Mfg. Co., LLC, Integra LifeSciences Corporation, Kai Industries Co., Ltd., Kawamoto Corporation, Leica Biosystems Nussloch GmbH, MANI, Inc., Medicom Company, Medtronic Plc., MYCO Medical, pfm medical, PL Medical Co., LLC., SouthMedic, Surgical Specialties Corporation, Swann-Morton Limited, VOGT Medical, and others.

Browse Complete Report Details @ https://www.marketresearchfuture.com/reports/surgical-scalpel-market-7581

Latest Trending Reports

Syringe and Needle Market Research Report - Global Forecast to 2027

Global Pacemaker Market Research Report- Forecast To 2022

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Medical Marijuana Market 2023 Growth Sales Analysis Global Industry Size, Share, Emerging Trends

Medical Marijuana Market: Information by Product Type (Solid, Gas and Dissolvable/Powders), Application (Alzheimer’s Disease, Cancer, Schizophrenia and Multiple Sclerosis), Distribution Channel (Retail & Pharmacy Stores, Online Platforms) and Region - Forecast till 2023

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/6470

Market Highlights

The Global Medical Marijuana Market is expected to register a CAGR of 34.0% to reach USD 54,677.1 Million by 2023.

Marijuana is a plant having some chemical compound “cannabis” that has medical property. This plant is used as a raw material by various pharmaceutical companies to manufacture drugs for various therapeutic applications. Marijuana plants extracts are used to treat the disease and various conditions caused by the disease such as the central nervous system, cancer, Alzheimer’s and used in anti-aging products.

Segment Analysis

The global medical marijuana market is segmented into product type, application, and distribution channel. On the basis of product type, the market is segmented into solids, dissolvable/powders, oil, and ointments & creams. The dissolvable/powders segment is expected to lead the market and register a substantial CAGR to reach USD 22,648.8 million by the end of 2023. Due to the affordability and convenience in using drives, the demand for this segment. The global medical marijuana market by application is segmented into Alzheimer’s disease, cancer, schizophrenia, and multiple sclerosis. On the basis of distribution channel, the market is segmented into retail & pharmacy stores, online platforms, and others.

Market Players

Market Research Future (MRFR) recognizes Canopy Growth Corporation (US), Cannabis Sativa Inc (Nevada), GW Pharmaceuticals Plc (US), Emerald Health Therapeutics Inc. (Victoria, BC), Tilray (Nanaimo, BC), Aphria (Ontario), CanniMed Ltd (Canada), Cara Therapeutics (US), Pfizer Inc. (US), Medical Marijuana Inc(US), GBSciences Inc.( Nevada) and MediPharm Labs(US).as the key players in the global medical Marijuana Market Growth

Regional Analysis

Geographically, the global medical marijuana market has been segmented into North America, Europe, Asia-Pacific, and the Middle East & Africa. As per MRFR analysis, the Americas was the largest market for medical marijuana in 2017 and is expected to remain dominant during the review period. Europe accounted for a significant market share and is projected to be the second-largest market during the forecast period. Major factors influencing the growth of the market increasing demand for marijuana-based medicines for the treatment of chronic diseases such as Alzheimer, Cancer, and respiratory problems. The Asia-Pacific medical marijuana market is one of the fastest growing regions across the globe.

Browse Full Report Details @ https://www.marketresearchfuture.com/reports/medical-marijuana-market-6470

 Related Reports

Global Patient Access Solutions Market

oppiods Market

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 

Nuclear Medicine Devices Market Challenges Report Analysis Overview by Top Companies 2024

Global Nuclear Imaging Devices Market Research Report: Information by Technology (PET, SPECT (Hybrid SPECT Systems and Standalone SPECT Systems) and Planar Scintigraphy)), Application (Oncology, Cardiology, Neurology and others), End User (Hospitals, Diagnostic Imaging Centers and others) and Region - Global Forecast till 2024

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/8014

Market Highlights

The global nuclear imaging devices market is expected to grow significantly over the forecast period. It is anticipated that the market held a valuation of USD 2490 million in 2018 and is projected to register a CAGR of 5.2% over the forecast period.

The increasing prevalence of cardiovascular disorders is one of the key factors driving the nuclear imaging devices market. As per the report published by the Centers for Disease Control and Prevention (CDC) in 2017, nearly 92.1 million adults were dealing with at least one type of cardiovascular disease

Segmentation

The global nuclear imaging devices market is segmented based on technology, application, end user, and region.

The global market for nuclear imaging devices, by technology, is segmented into positron emission tomography (PET), single photon emission computed tomography (SPECT), and planar scintigraphy. The single-photon-emission computed tomography (SPECT) are further classified as hybrid SPECT systems and standalone SPECT systems.

Based on application, the nuclear medicine devices market is segmented into oncology, cardiology, neurology, and others.

Based on end user, the market is segmented into hospitals, diagnostic imaging centers, and others.

The diagnostic imaging centers segment is expected to witness the fastest growth over the forecast period due to rising adoption of nuclear imaging in diagnostic centers.

Key Players

Some of the key players in the global nuclear imaging devices market are Philips Healthcare, Digirad Corporation, Neusoft Medical Systems Co., Ltd., Progenics Pharmaceuticals Inc., Cannon Inc., Surgiceye GmbH, CMR Naviscan, Mediso Medical Imaging Systems Ltd., Agfa-Gevaert Group, General Electric Company, DDD-Diagnostic A/S, Spectrum Dynamics Medical, FMI Medical Systems, Inc., Segamicorp, and others.

Access Report Details @ https://www.marketresearchfuture.com/reports/nuclear-imaging-devices-market-8014

Related Reports

Cancer Registry Software Market growth

closed system drug transfer device market share

 About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Global Smart Inhalers Market Forecast Overview Growth Forecast 2023 Analysis

Global Smart Inhalers Market Share, Trends and Growth Analysis by Type (Dry Powder Inhaler and Metered Dose Inhaler), Application (Asthma, Chronic Obstructive Pulmonary Disease and others), End User (Hospitals & Clinics, Respiratory Care Centers and others) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2025

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/2117

Global Smart Inhalers Market   - Overview

Smart Inhaler is a part of new age digital technology which is designed to improve the disease management in the respiratory diseases. Smart Inhalers are basically the respiratory inhalers equipped with a digital sensor. The sensor installed in the inhaler tracks the data such as the dosage timing, monitors the use of the inhaler, and schedules the next dosage. Smart Inhalers can generate alerts for the daily dosage for the user using the smart devices connected to the sensors via Bluetooth.

 

Global Smart Inhalers Market - Competitive Analysis

The Global Smart Inhalers Market for smart inhalers is characterised by the presence of several well-established and small players, the Global market of smart inhalers appears to be highly competitive and fragmented. Major players are increasingly expanding their footprint in the emerging nations, making it putting pressure on the regional players, especially in terms of features such as type, product portfolios, and pricing. The market is witnessing intensified competition which is expected to get more intensified further during the forecast period. There has been rise in number of companies that are adopting this digital technology and opting to use it to enhance the management of lung disorders such as asthma and chronic obstructive pulmonary disorder (COPD), as well as improve the efficacy of the prescribed medications.        

For instance, Adherium’s partnering and market expansion for the ‘Rest of World’ territories, including countries in Asia Pacific and the Middle East where Adherium already has sanctions to market its Smartinhaler products in China, Australia and New Zealand. This will increase the company’s strength in these countries.

Moreover, AstraZeneca, multinational pharmaceutical and biopharmaceutical Company had recently started its expansion in respiratory business with the acquisition of respiratory business of Tadeka Pharmaceuticals in 2016, and also with partnership with Adherium, for the supplies of smart inhaler and sensors.

In January 2017, AstraZeneca announced that on 25 January 2017 the US Food and Drug Administration (FDA) granted six months of paediatric exclusivity for Symbicort (budesonide/formoterol) Inhalation Aerosol. Symbicort is approved in the US to treat asthma in patients 12 years and older and for the maintenance and treatment of COPD in adults, the company is expecting larger market share with the product launch.

Gecko Health Innovations, Inc., acquired by Teva Pharmaceutical in 2015, focusing on cloud-based solution to simplify chronic respiratory disease management, and connect patients and caregivers through remote monitoring and real-time tools. The major driving factors for the company’s growth in the market are due to increasing technological advancements and need for integrated cloud based technologies in the treatment of respiratory diseases.

Browse Full Report @ https://www.marketresearchfuture.com/reports/smart-inhalers-market-2117

Related Reports

Wearable Sensors Market by type

nuclear medicine devices market

Key Players:

Adherium Limited (New Zealand), AstraZeneca (England), Cohero Health (USA), GlaxoSmithKline (U.K.), Gecko Health Innovations Inc (USA), Inspiro Medical Ltd., and Propeller Health (USA) are some of the prominent players at the forefront of competition in the Global Smart Inhalers Market and are profiled in MRFR Analysis. 

 

 

Musculoskeletal Disorders drugs Market size by country Growth 2020 Overview, Segments, Regional Analysis

Market Synopsis

The number of musculoskeletal system disorder cases is increasing globally, fueling market growth. Musculoskeletal system disorders are the second-highest contributor to global disability and an estimated 20%–33% of people across the globe live with a painful musculoskeletal condition.

Musculoskeletal disorders are most common in low- and middle-income countries and these disorders require lifelong care to manage

Request Sample Pages: 

https://www.marketresearchfuture.com/sample_request/8232

Market Highlights

According to MRFR analysis, the global musculoskeletal system disorders market is expected to register a CAGR of ~5.30% during the forecast period of 2019 to 2025 and was valued at USD 3837.7 million in 2018.

Musculoskeletal system disorders affect movement or musculoskeletal systems such as muscles, tendons, and ligaments. These disorders are also known as repetitive motion injuries. Musculoskeletal system disorders can arise by making the same motion repeatedly or lifting heavy objects. They affect different parts of the body, mainly the upper and lower back and neck.

Segmentation

The global Musculoskeletal Disorders drugs Market has been segmented based on type, treatment, and end user.

The market, based on type, has been divided into rheumatoid arthritis, osteoarthritis, osteoporosis, psoriatic arthritis, ankylosing spondylitis, fibromyalgia, and others. The rheumatoid arthritis segment is likely to be the largest during the review period due to a growing aging population and increasing prevalence of rheumatoid arthritis globally. Around 1.3 million Americans are diagnosed with rheumatoid arthritis every year. The osteoarthritis segment is predicted to be the fastest-growing due to the rising prevalence of the disorder in the elderly.  

The global musculoskeletal system disorders market has been segmented, on the basis of treatment, into corticosteroids, biologics, physical therapy, extracorporeal shock wave therapy, protein therapy, synthetic bone graft, composite grafts, demineralized bone matrix, and others. The corticosteroids segment is expected to hold the majority share of the market the drugs help increase muscle strength and quicken the recovery process. The biologics segment is expected to be the fastest-growing due to the increasing use of biologics in the treatment of musculoskeletal system disorders. iologic therapies include alpha (TNF-α) blockers that help reduce muscle and joint pain. The cost of the treatment is also less as compared to other treatment types.

The end user segments of the market are hospitals and clinics, ambulatory surgical centers, and others. The hospitals and clinics segment is expected to hold the largest share of the market as these centers are the primary locations for patients receiving treatment and surgery.

Access Report Details @ https://www.marketresearchfuture.com/reports/musculoskeletal-system-disorders-market-8232

Related Reports

Wearable Sensors Market by type

Global Smart Inhalers Market

 Key Players

Some of the key players in the global musculoskeletal system disorders market are AB Science (France), AbGenomics International, Inc. (US), Alder BioPharmaceuticals,Inc. (US), Amgen Inc. (US), Lexicon Pharmaceuticals, Inc. (US), LG Chem (South Korea), OrthoTrophix, Inc. (US), Tarsa Therapeutics, Inc. (US), PhytoHealth Corporation (Taiwan), Eisai Co., Ltd (Japan), Astellas Pharma Inc. (Japan),  AstraZeneca (UK), Baxter (US), and GlaxoSmithKline PLC (UK).

Bipolar Disorders therapy Market Growth 2020 Overview, Segments, Regional Analysis

Global Bipolar Disorders Treatment Market Research Report: Information by Drug Type (Mood Stabilizer, Anticonvulsant, Antipsychotic Drug, and Antidepressant Drug), Mechanism of Action (Selective Serotonin Reuptake Inhibitor, Serotonin Norepinephrine Reuptake Inhibitor, Monoamine Oxidase Inhibitors, Beta Blockers, and Tricyclic Antidepressant Drug), End User (Hospitals and Clinics, Multispecialty Centers, and Others), and Region (the Americas, Europe, Asia-Pacific, and the Middle East & Africa)—Forecast till 2025 Market 

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/1566

Global Bipolar Disorders and Treatment Market   - Overview

The global bipolar disorders and treatment market is growing with the rapid pace; mainly due to the increasing stress in life. According to a recent study report published by the Market Research Future, The global bipolar disorders and treatment market is booming and expected to gain prominence over the forecast period growing rapidly .The market is forecasted to demonstrate a spectacular growth by 2022, surpassing its previous growth records in terms of value with a striking CAGR during the anticipated period (2017 – 2022).  

 Global Bipolar Disorders and Treatment Market   - Competitive Analysis

AstraZeneca (U.K), Bristol-Myers Squibb (U.S), Eli Lilly and Company (U.S), GlaxoSmithKline PLC (U.K), Allergan (U.S), Janssen Pharmaceuticals (Belgium), Dainippon Sumitomo Pharma Co., Ltd (Japan), Lundbeck (Denmark), Abbott (U.S.), Cephalon Inc. (Teva Phamaceuticals), Dainippon Sumitomo Pharma Co. Ltd., Forest Laboratories Inc. (U.S.), Gedeon Richter PLC (Hungary), Otsuka America Pharmaceutical Inc., (U.S.) Repligen Corporation, (U.S.) and Pfizer Inc. (U.S.)  are some of the prominent players at the forefront of competition in the Global Bipolar Disorders and Treatment Market and are profiled in MRFR Analysis. 

July, 2017- Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S announced ABILIFY MAINTENA (Aripiprazole) injectable suspension whcih is approved by U.S. FDA for maintenance monotherapy treatment of Bipolar I disorder. According to otsuka company reports ABILIFY MAINTENA is a once a monthly injectable formulation for intramuscular and has been co-developed and co-commercialized with Lundbeck. Based on Phase 3 study data, ABILIFY MAINTENA delayed the time to recurrence of any mood episode in adult patients experiencing a manic episode at screening compared to placebo.

North America dominates the global bipolar Disorders therapy Market owing to increased awareness about bipolar disorder in the region and presence of major market players. The U.S. represents the largest market for bipolar disorder followed by Canada in North America region.

According to the National Institute of Mental Health (NIMH), bipolar disorder affects more than 5.7 million adults (about 3 % of the population) in the United States each year. The typical age is the late teens or early 20s, and a history of depression is common in people diagnosed with bipolar.

Access Report Details @ https://www.marketresearchfuture.com/reports/bipolar-disorders-treatment-market-1566

Related Reports:

hazmat suits market by types

non-invasive blood glucose monitoring devices market

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Alpha-1 Antitrypsin Deficiency Treatment Market analysis Forecast Overview Growth Forecast 2023

Market Forecast

Registering a CAGR of 10.50%, the Global Alpha-1 Antitrypsin Deficiency Treatment Market is expected to grow from USD 1,464.1 Million in 2018 to USD 2,914.7 Million by 2025.

As of July 2019, 3.4 million people are affected by alpha-1 antitrypsin deficiency worldwide. The disorder is found to affect populations in all the regions of the world.

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/8319

Segmentation

By Drugs:

  • Alpha-1 Proteinase Inhibitor: The segment is expected to hold the largest market share as it is the only treatment for AATD, which protects the patient from more lung damage.
  • Bronchodilators: These are used for the treatment of respiratory disorders associated with AATD.
  • Steroids: These are used specifically for the treatment of chronic obstructive pulmonary disease, which affects the patient along with AATD.
  • Others: Other treatment options include antibiotics for infections and jaundice associated with AATD and oxygen therapy.

By Route of Administration:

  • Oral: The segment is expected to hold the largest market share.
  • Intravenous: The segment is expected to grow at the fastest CAGR.
  • Inhalation: This route of administration is used specifically for the administration of corticosteroids for treating breathing disorders.
  • Others: Subcutaneous and intramuscular routes of administration.

By Distribution Channel:

  • Hospital Pharmacy: The rise in the number of hospitals is likely to be responsible for the largest market size.
  • Retail Pharmacy: These fulfill the requirement of drugs that are needed for treatment at home.
  • Online Stores: The fastest-growing segment owing to increase in number of online pharmacies.

 

Market Influencer

The prevalence of alpha-1 antitrypsin deficiency (AATD) is increasing, which is directly responsible for the growth of the global Alpha-1 Antitrypsin Deficiency Treatment Market analysis. Strategic initiatives, mergers & acquisitions, partnerships, agreements, product launches, government approvals, and expansion of manufacturing facilities by major competitors are expected to further boost market growth during the forecast period.

Key Players

  • Kamada Pharmaceuticals (Israel)
  • CSL Behring LLC (US)
  • Grifols, S.A. (Spain)
  • Takeda Pharmaceutical Company Limited (Japan)
  • GlaxoSmithKline plc (UK)
  • Boehringer Ingelheim GmbH (Germany)
  • AstraZeneca (UK)
  • Vectura Group plc (UK)
  • Pfizer Inc. (US)
  • Mylan Inc. (US)

Browse Full Report Details @ https://www.marketresearchfuture.com/reports/alpha-1-antitrypsin-deficiency-treatment-market-8319

 

Related Reports:

Bipolar Disorders therapy Market

Musculoskeletal Disorders drugs Market

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 

Global newborn screening market 2025 Trends Analysis, Upcoming Trends, Emerging Growth, Key Players

Global New-Born Screening Market: Information by Product (Reagents and Assay Kits and Instruments), by Technology (Tandem Mass Spectrometry, Immunoassays and Enzymatic Assays, Hearing Screening Technology, DNA Assays and Pulse Oximetry), by Test Type (Dry Blood Spot Test, Hearing Screening Test and Critical Congenital Heart Disease (CCHD) Test), by End User (Hospitals, Maternity and Specialty Clinics and Diagnostic Centers) and by Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2025

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/6561

Market Highlights

The Global New-Born Screening Market is expected to register a CAGR of 13.33% during the forecast period with a market value of USD 1545.98 Million till 2025. Newborn screening is the practice of testing every newborn for some harmful or possibly fatal disorders that are not otherwise obvious at birth. New-born screening involves the use of various devices for the screening procedure. Diseases such as phenylketonuria, congenital hypothyroidism, galactosemia, sickle cell disease, cystic fibrosis, tyrosinemia, and other such disorders can be screened using new-born screening devices. The rising prevalence of neonatal conditions and government support along with new-born screening programs have led to the growth of the new-born screening market in recent years. Additionally, increasing neonatal population and technological advancements are likely to contribute to the growth of the market over the assessment period.

Regional Analysis

The global new-born screening market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas are anticipated to hold a significant share in the global new-born screening market. According to data published by the Centers for Disease Control and Prevention (CDC) in November 2018, congenital heart defects (CHD) affect approximately 1% or about 40,000 births per year in the US. Also, increasing awareness and rising demand for new-born screening are expected to drive market growth.

The Global newborn screening market in Europe is expected to propel owing to factors such as the rising prevalence of neonatal disorders and raising awareness about these disorders and their screening programs. According to a report published by the European Medicines Agency in May 2015, 1 in 10,000 babies born in the European Union was affected by perinatal asphyxia (a neonatal disorder wherein babies are born without enough oxygen in the blood). Also, technological advancements in the industry and government support in terms of National Health Service and health insurance are expected to drive market growth.

Asia-Pacific is anticipated to be the fastest-growing region in the global new-born screening market owing to the rising neonatal population, increasing mortality rate of neonates, and improving healthcare infrastructure. According to data published by the United Nation’s International Children’s Emergency Fund (UNICEF), the rate of neonatal mortality in India was 24% in 2017. According to a report published by the National Center for Biotechnology Information (NCBI) in December 2016, approximately 0.75 million neonates die in India every year. The neonatal mortality rate (NMR) for India is the highest for any country in the world. Also, the rising prevalence of neonatal disorders in developing countries and government support is fueling the growth in the market.

The new-born screening market in the Middle East & Africa is expected to significantly grow owing to the developing healthcare infrastructure and government support. The American Society of Hematology (ASH), led a campaign to fight the sickle cell disease in Africa in June 2018. It also urged the governments, particularly in Sub-Saharan Africa, to invest in new-born screening of the disease. Additionally, raising awareness of newborn screening is fueling the growth in the market.

Browse Full Report Details @ https://www.marketresearchfuture.com/reports/new-born-screening-market-6561

Key Players

MRFR recognizes the following companies as the Key Players in the Global New-Born Screening Market—SCIEX (US), PerkinElmer Inc. (US), WATERS (US), Natus Medical Incorporated (US), Masimo Corporation (US), Agilent Technologies Inc. (US), Bio-Rad Laboratories, Inc. (US), Medtronic (Ireland), GENERAL ELECTRIC (Boston), Trivitron Healthcare (India), and ZenTech SA (Belgium)

 Related Reports:

hearing aids market technology

Alpha-1 Antitrypsin Deficiency Treatment Market analysis

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Global Biopharmaceuticals Market 2025 Trends Analysis, Upcoming Trends, Emerging Growth, Key Players

Market Highlights

According to MRFR analysis, Biopharmaceuticals Market is expected to register a CAGR of 8.99% during the forecast period of 2019 to 2025 and was valued at USD 238,192.7 million in 2018.

Biopharmaceuticals are also known as biological, medical products, or biologics, are pharmaceutical drugs manufactured, extracted, or synthesized using biological sources, such as bacteria, yeast, and mammalian cells.

Request Sample Pages @ https://www.marketresearchfuture.com/sample_request/8439

Market Highlights

According to MRFR analysis, Biopharmaceuticals Market is expected to register a CAGR of 8.99% during the forecast period of 2019 to 2025 and was valued at USD 238,192.7 million in 2018.

Biopharmaceuticals are also known as biological, medical products, or biologics, are pharmaceutical drugs manufactured, extracted, or synthesized using biological sources, such as bacteria, yeast, and mammalian cells.

The global biopharmaceuticals market is growing owing to various factors such as increasing investment by major companies on research & development of biopharmaceuticals and increasing acceptance for biopharmaceuticals due to their ability to treat the previously untreatable diseases. Furthermore, the number of geriatric populations is, tremendously, the incidence rate of chronic diseases is also high, and technological advancements are growing which are also expected to fuel the market growth. However, the entry of low-cost biosimilars, risk of side effects that can occur due to high usage of biopharmaceuticals, and stringent government regulations are expected to pose as restraints to the growth of the global biopharmaceuticals market.

Key Players

Some of the key players in the Global Biopharmaceuticals Market are Pfizer Inc. (US), Amgen Inc. (US), Eli Lilly and Company (US), F. Hoffmann-La Roche Ltd (Switzerland), Johnson & Johnson (US), Gilead Sciences, Inc. (US), AstraZeneca (UK), Abbvie Inc. (US), Sanofi (France), Bristol-Myers Squibb Company (US), Sandoz International GmbH (Germany), Novo Nordisk A/S (Denmark), GlaxoSmithKline PLC (UK), Merck KGaA (Germany), and Biocon (India).

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to be the largest market owing to the increasing prevalence of chronic diseases. The biopharmaceuticals market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European biopharmaceuticals market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The biopharmaceuticals market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the increasing patient pool suffering from various chronic diseases and a supportive regulatory framework, the market in Asia-Pacific is expected to be the fastest-growing. The biopharmaceuticals market in the Middle East & Africa has been divided into the Middle East and Africa.

Browse Full Report Details @ https://www.marketresearchfuture.com/reports/biopharmaceuticals-market-8439

 Related Reports:

Global newborn screening market

nipt market

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 

Behavioral Health Services Market 2025 Trends Analysis, Upcoming Trends, Emerging Growth, Key Players

Market Highlights

 

According to MRFR analysis, Behavioral Health Services Market is expected to register a CAGR of 3.4% during the forecast period of 2019 to 2025 and was valued at USD 146.3 Billion by 2025.

 

Behavior health services provide services to patients with mental health disorders, substance abuse disorders, and other mental disorders. Behavioral health includes conditions such as depression, anxiety, substance abuse, and others. Around 83% people in the US are suffering from behavioral health issues. According to Japanese study around 298 people were suffering from various behavioral disorders in 2018

 

Request Sample Pages @ https://www.marketresearchfuture.com/sample_request/8433

 

Segmentation

 

The Global Behavioral Health Services Market has been segmented based on services type, disorder type, and end user.

 

The market, based on services type, has been divided into inpatient hospital treatment, outpatient counseling, home-based treatment services, emergency mental health services, and others. The inpatient hospital treatment segment is likely to be the largest during the review period due to a growing aging population globally. Around 1.3 million Americans are diagnosed with various behavioral disorders every year. The outpatient counseling segment is predicted to be the fastest-growing due to the rising prevalence of the disorder in the elderly population.  

 

The global Behavioral Healthcare Market size has been segmented on the basis of disorder type, into anxiety disorder, bipolar disorders, depression, eating disorder, post-traumatic stress disorder (PSTD), substance abuse disorder, and others.  The anxiety disorder segment is expected to hold the majority share of the market. Rising prevalence of anxiety disorder in most commonly seen in US. Around 40 million adults are diagnosed with anxiety disorder every year. The bipolar disorder segment is expected to be the fastest-growing due to its rising prevalence globally. It was estimated that around 7 million people in US were suffering through bipolar disorder in 2018.

 

The end user segments of the market are providers, patients, and others. The providers segment is expected to hold the largest share of the market as these centers are the primary locations for patients receiving treatment and services.

 

Key Players

 

Some of the key players in the global Behavioral Health Services market are Acadia Healthcare (US), National Mentor Holdings Inc (US), Behavioral Health Services Inc (US), Ocean Mental Health Services Inc (US), The MENTOR Network (US), Universal Health Services, Inc (US),  Behavioral Health Network, Inc (US), CareTech Holdings PLC (UK), Strategic Behavioral Health (US), North Range Behavioral Health (US), Pyramid Healthcare (US), Promises Behavioral Health (US), and others.

 

Browse Full Report Details

https://www.marketresearchfuture.com/reports/behavioral-health-services-market-8433

 

Related Reports:

 

hip implants market by type

lymphedema treatment market by types

 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.